SCHEMBL23534299

SCHEMBL23534299

CC(C)(C)OC(=O)N1CCC(NC(=O)c2c[nH]c3ncc(Br)cc23)CC1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ L3MBTL1 Q9Y468 1/20 0.49
▸ MEN1 O00255 4/20 0.48
▸ KMT2A Q03164 4/20 0.48
▸ ALDH1A1 P00352 3/20 0.48
▸ JAK1 P23458 1/20 0.48
▸ KDM4E B2RXH2 1/20 0.47
▸ CRHBP P24387 1/20 0.47
▸ CRHR2 Q13324 1/20 0.47
▸ POLB P06746 2/20 0.47
▸ BTK Q06187 2/20 0.47
▸ LMNA P02545 2/20 0.45
▸ THRB P10828 1/20 0.45
▸ ALPL P05186 1/20 0.45
▸ ALPI P09923 1/20 0.45
▸ ALPG P10696 1/20 0.45
▸ PARP1 P09874 1/20 0.45
▸ USP30 Q70CQ3 2/20 0.45
▸ MAPT P10636 2/20 0.45
▸ MAPK1 P28482 1/20 0.45
▸ NPSR1 Q6W5P4 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28579659 0.82 USP30 (0.52) L3MBTL1MEN1KMT2AALDH1A1KDM4E
SCHEMBL29753928 0.80 WNT1 (0.47) L3MBTL1MEN1KMT2AALDH1A1JAK1
SCHEMBL22208416 0.77 PIK3CG (0.50) JAK1BTK
SCHEMBL32669055 0.76 JAK1 (0.51) L3MBTL1ALDH1A1JAK1BTKMAPT
SCHEMBL21678742 0.76 JAK1 (0.51) L3MBTL1ALDH1A1JAK1BTKMAPT
SCHEMBL31171376 0.76 POLB (0.52) L3MBTL1MEN1KMT2AALDH1A1POLB
SCHEMBL13503144 0.75 ALPL (0.51) L3MBTL1MEN1KMT2AALDH1A1KDM4E
SCHEMBL27043050 0.74 PIK3CG (0.40) JAK1
SCHEMBL1802576 0.74 JAK1 (0.45) MEN1KMT2AALDH1A1JAK1KDM4E
SCHEMBL23533928 0.74 USP30 (0.54) MEN1KMT2AALDH1A1POLBLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250243181-A2 NOVEL INDAZOLE DERIVATIVE AND USE THEREOF KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) 2025-07-31 — — US disclosed
US-20230116733-A1 NOVEL INDAZOLE DERIVATIVE AND USE THEREOF KOREA RESEARCH INSTITUTE OFCHEMICAL TECHNOLOGY (KR) 2023-04-13 — — US disclosed
EP-4079732-A1 NOVEL INDAZOLE DERIVATIVE, AND USE THEREOF Korea Research Institute of Chemical Technology (KR) 2022-10-26 — — EP disclosed
WO-2021125802-A1 NOVEL INDAZOLE DERIVATIVE, AND USE THEREOF 한국화학연구원 2021-06-24 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250243181-A2 NOVEL INDAZOLE DERIVATIVE AND USE THEREOF TRIB2, YAP1, IDO2 L3MBTL1 1099/4885MEN1 3559/4885KMT2A 1433/4885
US-20230116733-A1 NOVEL INDAZOLE DERIVATIVE AND USE THEREOF TRIB2, YAP1, IDO2 L3MBTL1 1099/4885MEN1 3559/4885KMT2A 1433/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback